Immunotherapy before surgery shows promise for lung nodules
NCT ID NCT04047186
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This pilot study tested giving an immunotherapy drug (anti-PD-1) before surgery to 12 people with early-stage lung cancer who also had multiple ground-glass nodules in their lungs. The goal was to see if the drug could shrink tumors before surgery. The study measured how well the tumors responded and tracked any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE PULMONARY NODULES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.